{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T06:57:59Z","timestamp":1772002679396,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007566","name":"City, University of London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007566","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010313","name":"Heidelberg Engineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002806","name":"Carl Zeiss Meditec AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002806","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007826","name":"American Glaucoma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001608","name":"EyeSight Foundation of Alabama","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007911","name":"University of California, San Diego","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007911","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008310","name":"Edith C. Blum Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008310","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY08208"],"award-info":[{"award-number":["EY08208"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["U10EY14267"],"award-info":[{"award-number":["U10EY14267"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["1EY027510"],"award-info":[{"award-number":["1EY027510"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY13959"],"award-info":[{"award-number":["EY13959"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY019869"],"award-info":[{"award-number":["EY019869"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY025253"],"award-info":[{"award-number":["EY025253"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY11008"],"award-info":[{"award-number":["EY11008"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005616","name":"Allergan Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005616","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006474","name":"Columbia University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006474","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ajo.2018.01.001","type":"journal-article","created":{"date-parts":[[2018,1,6]],"date-time":"2018-01-06T03:26:14Z","timestamp":1515209174000},"page":"92-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Baseline 24-2 Central Visual Field Damage Is Predictive of Global Progressive Field Loss"],"prefix":"10.1016","volume":"187","author":[{"given":"Aakriti","family":"Garg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Gustavo","family":"De Moraes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George A.","family":"Cioffi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher A.","family":"Girkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe A.","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert N.","family":"Weinreb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda M.","family":"Zangwill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey M.","family":"Liebmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2018.01.001_bib1","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2018.01.001_bib2","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1001\/archophthalmol.2009.165","article-title":"Glaucoma with early visual field loss affecting both hemifields and the risk of disease progression","volume":"127","author":"De Moraes","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2018.01.001_bib3","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ajo.2012.05.025","article-title":"Comparison of the progression rates of the superior, inferior, and both hemifield defects in normal-tension glaucoma patients","volume":"154","author":"Cho","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2018.01.001_bib4","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/bjo.84.10.1154","article-title":"Comparison of visual field progression in patients with normal pressure glaucoma between eyes with and without visual field loss that threatens fixation","volume":"84","author":"Membrey","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2018.01.001_bib5","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/jamaophthalmol.2017.1396","article-title":"Association between undetected 10-2 visual field damage and vision-related quality of life in patients with glaucoma","volume":"135","author":"Blumberg","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2018.01.001_bib6","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/jamaophthalmol.2017.1659","article-title":"Association of glaucoma-related, optical coherence tomography-measured macular damage with vision-related quality of life","volume":"135","author":"Prager","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2018.01.001_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ajo.2015.12.006","article-title":"The impact of visual field clusters on performance-based measures and vision-related quality of life in patients with glaucoma","volume":"163","author":"Sun","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2018.01.001_bib8","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/jamaophthalmol.2015.3426","article-title":"Relationships between measures of the ability to perform vision-related activities, vision-related quality of life, and clinical findings in patients with glaucoma","volume":"133","author":"Ekici","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2018.01.001_bib9","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ophtha.2015.10.046","article-title":"The impact of location of progressive visual field loss on longitudinal changes in quality of life of patients with glaucoma","volume":"123","author":"Abe","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2018.01.001_bib10","first-page":"914","article-title":"[Reading performance in patients with central visual field disturbance due to glaucoma]","volume":"110","author":"Fujita","year":"2006","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.ajo.2018.01.001_bib11","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0042-6989(01)00297-8","article-title":"The effect of visual field defects on eye movements and practical fitness to drive","volume":"42","author":"Coeckelbergh","year":"2002","journal-title":"Vision Res"},{"key":"10.1016\/j.ajo.2018.01.001_bib12","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/archophthalmol.2009.187","article-title":"The African Descent and Glaucoma Evaluation Study (ADAGES): design and baseline data","volume":"127","author":"Sample","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2018.01.001_bib13","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ophtha.2007.08.037","article-title":"Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino Eye Study","volume":"115","author":"McKean-Cowdin","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2018.01.001_bib14","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ajo.2007.02.022","article-title":"Los Angeles Latino Eye Study Group, Severity of visual field loss and health-related quality of life","volume":"143","author":"McKean-Cowdin","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2018.01.001_bib15","first-page":"1","article-title":"Studies on computerized perimetry","volume":"132","author":"Heijl","year":"1977","journal-title":"Acta Ophthalmol Suppl"},{"key":"10.1016\/j.ajo.2018.01.001_bib16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0002-9394(71)91314-6","article-title":"Peripheral nasal field defects","volume":"72","author":"LeBlanc","year":"1971","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2018.01.001_bib17","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/S0161-6420(79)35335-0","article-title":"Peripheral nasal field defects in glaucoma","volume":"86","author":"Werner","year":"1979","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2018.01.001_bib18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/eye.2013.285","article-title":"Initial central scotomas vs peripheral scotomas in normal-tension glaucoma: clinical characteristics and progression rates","volume":"28","author":"Cho","year":"2014","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ajo.2018.01.001_bib19","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1167\/iovs.12-10833","article-title":"Global and pointwise rates of decay in glaucoma eyes deteriorating according to pointwise event analysis","volume":"54","author":"Nassiri","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2018.01.001_bib20","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3109\/02713683.2013.867353","article-title":"Prediction of glaucomatous visual field progression: pointwise analysis","volume":"39","author":"Shon","year":"2014","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ajo.2018.01.001_bib21","first-page":"539","article-title":"Visual prognosis in advanced glaucoma: a comparison of medical and surgical therapy for retention of vision in 101 eyes with advanced glaucoma","volume":"75","author":"Kolker","year":"1977","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ajo.2018.01.001_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1167\/tvst.5.2.15","article-title":"The 24-2 visual field test misses central macular damage confirmed by the 10-2 visual field test and optical coherence tomography","volume":"5","author":"Grillo","year":"2016","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.ajo.2018.01.001_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ajo.2017.01.001","article-title":"Relationship between central retinal vessel trunk location and visual field loss in glaucoma","volume":"176","author":"Wang","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2018.01.001_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1167\/tvst.1.1.3","article-title":"The nature of macular damage in glaucoma as revealed by averaging optical coherence tomography data","volume":"1","author":"Hood","year":"2012","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.ajo.2018.01.001_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/archopht.1981.03930010139020","article-title":"Regional differences in the structure of the lamina cribrosa and their relation to glaucomatous optic nerve damage","volume":"99","author":"Quigley","year":"1981","journal-title":"Arch Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939418300023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939418300023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:40:52Z","timestamp":1762080052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939418300023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":25,"alternative-id":["S0002939418300023"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2018.01.001","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Baseline 24-2 Central Visual Field Damage Is Predictive of Global Progressive Field Loss","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2018.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}